Lataa...
Primary hypothyroidism and isolated ACTH deficiency induced by nivolumab therapy: Case report and review
RATIONALE: Nivolumab is a monoclonal IgG antibody blocking programmed death receptor-1 (PD1), leading to restoration of the natural T-cell-mediated immune response against the cancer cells. However, it also causes plenty of autoimmune-related adverse events, which often involves endocrine system. PA...
Tallennettuna:
| Julkaisussa: | Medicine (Baltimore) |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wolters Kluwer Health
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5682799/ https://ncbi.nlm.nih.gov/pubmed/29095280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000008426 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|